Improving Compliance with Statins in Patients with Peripheral Arterial Disease: A Quality Improvement Study

Annals of Medicine and Surgery

Volumn 1, Issue , 2012, Pages 30-33

  Agha, Riaz A ^a   Camm, Christian F ^b   Edison, Eric ^c   Browning, Neil ^a  

^a ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEW COLLEGE   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Peripheral Artery Disease; Quality Improvement; Statins; Vascular Surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOPLASTY; ARTICLE; DIABETES MELLITUS; DRUG COST; EMBOLISM; HOSPITAL DISCHARGE; HUMAN; MEDICAL INFORMATION; OSTEOPOROSIS; PATIENT COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; UNSPECIFIED SIDE EFFECT;

EID: 84892884141     PISSN: 20490801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2049-0801(12)70010-9     Document Type: Article

References (29)

1. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 1999, 340(2):115-126.
2. Dormandy J.A., Rutherford R.B. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000, 31:S1-S296. Management of peripheral arterial disease (PAD). TASC Working Group.
3. Coppola G., Novo S. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Arch Med Res 2007, 38(5):479-488.
4. Toutouzas K., Drakopoulou M., Skoumas I., Stefanadis C. Advancing therapy for hypercholesterolemia. Expert Opin Pharmacother 2010, 11(10):1659-1672.
5. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandanavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-1389. The Scandanavian Simvastatin Survival Study.
6. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360(9326):7-22. Heart Protection Study Collaborative Group.
7. Momsen A.H., Jensen M.B., Norager C.B., Madsen M.R., Vestersgaard-Andersen T., Lindholt J.S. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 2009, 38(4):463-474.
8. Vascular Society of Great Britain and Ireland. The Provision of Services for Patients with Vascular Disease, 11 November 2011 [online]. Available from: (accessed 20 May 2012). http://www.vascularsociety.org.uk/news-and-press/2011/71-provision-of-services-for-patients-with-vascular-disease.html.
9. National Institute of Health and Clinical Excellence. Lower limb peripheral arterial disease draft scope for consultation, 9 March 2012 [online]. Available from: (accessed 20 May 2012). http://www.nice.org.uk/nicemedia/live/12343/58407/58407.pdf.
10. Scottish Intercollegiate Guidelines Network. Diagnosis and management of peripheral arterial disease, October 2006 [online]. Available from: (accessed 20 May 2012). http://www.sign.ac.uk/pdf/sign89.pdf.
11. Barry P.J., Gallagher P., Ryan C., O'Mahony D. START (screening tool to alert doctors to the right treatment) - an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007, 36(6):632-638.
12. Rzouq F.S., Volk M.L., Hatoum H.H., Talluri S.K., Mummadi R.R., Sood G.K. Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians. Am J Med Sci 2010, 340(2):89-93.
13. Kedward J., Dakin L. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care. Br J Gen Pract 2003, 53(494):684-689.
14. Yarzebski J., Bujor C., Goldber R.J., Spence F., Lessard D., Gore J.M. A community-wide survery of physician practices and attituteds towards cholesterol management in patients with recent acute myocardial infarction. Arch Intern Med 2002, 162(7):797-804.
15. AB E., Denig P., van Vliet T., Dekker J.H. Reasons of general practitioners for not prescribing lipid-lowering mediations to patients with diabetes: a qualitative study. BMC Fam Pract 2009, 10:24.
16. Cortet B., Blotman F., Debais F., et al. Management of osteoporosis and associated quality of life in post menopausal women. BMC Musculoskelet Disord 2011, 12:7.
17. Viskin S., Kitzis I., Lev E., et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 1995, 25(6):1327-1332.
18. Dr Foster Health.co.uk. Ashford and St. Peter's Hospital NHS Foundation Trust, March 2011 [online]. Available from: (accessed 20 May 2012). http://www.drfosterhealth.co.uk/hospital-guide/trust/Ashford-and-St.-Peter%E2%80%99s-Hospitals-NHS-Foundation-Trust-78.aspx.
19. World Health Organisation. International classificantion of Diseases (ICD), 2012 [online]. Available from: (accessed 20 May 2012). http://www.who.int/classifications/icd/en/.
20. Institute for Healthcare Improvement. How to Improve, 2012 [online]. Available from: (accessed 20 May 2012). http://www.ihi.org/knowledge/Pages/HowtoImprove/default.aspx.
21. London Deanery. Beyond audit, 2012 [online]. Available from: (accessed 20 May 2012). http://www.leadership.londondeanery.ac.uk/home/beyond-audit.
22. Perla R.J., Provost L.P., Murray S.K. The run chart: a simple analytical tool for learning from variation in healthcare processes. BMJ Qual Saf 2011, 20(1):46-51.
23. Kamugasha D, Hoffman A, Grant R, Lees T, Rudd A. UK Carotid Interventions Audit, 1 April 2008 [online]. Available from: (accessed 20 May 2012). http://www.rcplondon.ac.uk/sites/default/files/cia-audit-publicreport-dec-dec-2007.pdf.
24. Department of Health. NHS Outcomes Framework, 20 December 2010 [online]. Available from: (accessed 20 May 2012). http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd%20Guidance/DH_122944.
25. Reason J. Beyond the organizational accident: the need for "error wisdom" on the frontline. Qual Saf Health Care 2004, 13(Suppl II):ii28-ii33.
26. Reason J. Human error; models and management. BMJ 2000, 320(7237):768-770.
27. Chin M.H. Quality improvement implementation and disparities: the case of health disparities collaboratives. Med Care 2011, 49(Suppl):S65-S71.
28. BNF Online. Statins, March 2012 [online]. Available from (accessed 20 May 2012). http://www.medicinescomplete.com/mc/bnf/current/33422.htm.
29. National Institute of Health and Clinical Excellence. Costing statement: Inpatient management of diabetic foot problems, March 2011 [online] Available from: (accessed 20 May 2012). http://www.nice.org.uk/nicemedia/live/13416/53606/53606.pdf.